Chimerix Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
81
- Latest Deal Type
-
M&A
- Financing Rounds
-
20
- Investments
-
1
Chimerix General Information
Description
Developer of orally available antiviral therapeutics designed to treat viral diseases. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, as well as royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale.
Contact Information
Website
www.chimerix.com(Operating Subsidiary)
Corporate Office
- 2505 Meridian Parkway
- Suite 100
- Durham, NC 27713
- United States
Corporate Office
- 2505 Meridian Parkway
- Suite 100
- Durham, NC 27713
- United States
Chimerix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chimerix Patents
Chimerix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231725-A2 | Combination therapies for treatment of central nervous system cancers | Pending | 28-Apr-2025 | ||
| WO-2025250553-A1 | Solid state forms of imipridone derivative | Pending | 28-May-2024 | ||
| AU-2023320122-A1 | Pharmaceutical compositions and uses thereof for the treatment of glioma | Pending | 05-Aug-2022 | ||
| AU-2023320122-A2 | Pharmaceutical compositions and uses thereof for the treatment of glioma | Pending | 05-Aug-2022 | ||
| EP-4565237-A1 | Pharmaceutical compositions and uses thereof for the treatment of glioma | Pending | 05-Aug-2022 | C07D471/14 |
Chimerix Signals
Chimerix Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Chimerix Acquisitions (1)
Chimerix’s most recent deal was a Merger/Acquisition with Oncoceutics for . The deal was made on 07-Jan-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Oncoceutics | 07-Jan-2021 | Merger/Acquisition | Drug Discovery |
Chimerix FAQs
-
When was Chimerix founded?
Chimerix was founded in 2000.
-
Where is Chimerix headquartered?
Chimerix is headquartered in Durham, NC.
-
What is the size of Chimerix?
Chimerix has 81 total employees.
-
What industry is Chimerix in?
Chimerix’s primary industry is Drug Discovery.
-
Is Chimerix a private or public company?
Chimerix is a Private company.
-
What is the current valuation of Chimerix?
The current valuation of Chimerix is .
-
What is Chimerix’s current revenue?
The current revenue for Chimerix is .
-
How much funding has Chimerix raised over time?
Chimerix has raised $378M.
-
Who are Chimerix’s investors?
Aisling Capital, Alta Partners, Asset Management Ventures, Canaan Partners, and Frazier Healthcare Partners are 5 of 11 investors who have invested in Chimerix.
-
When was Chimerix acquired?
Chimerix was acquired on 21-Apr-2025.
-
Who acquired Chimerix?
Chimerix was acquired by Jazz Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process